Benchmark Holdings Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BGHPT808
GBP
0.22
0.01 (4.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Benchmark Holdings Plc stock-summary
stock-summary
Benchmark Holdings Plc
Pharmaceuticals & Biotechnology
Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.
Company Coordinates stock-summary
Company Details
Benchmark House, 8 Smithy Wood Drive , SHEFFIELD None : S35 1QN
stock-summary
Tel: 44 114 2409939
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Peter George
Non-Executive Chairman of the Board
Mr. Trond Williksen
Chief Executive Officer, Director
Mr. Kristian Eikre
Non-Executive Director
Mr. Yngve Myhre
Non-Executive Independent Director
Mr. Kevin Quinn
Non-Executive Independent Director
Ms. Susan Searle
Senior Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
23 Million
(Quarterly Results - Mar 2025)
Net Profit:
-6 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 136 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.21

stock-summary
Return on Equity

-5.34%

stock-summary
Price to Book

0.45